Table of Contents Bioregulator Peptides vs NMN: What’s the Difference? How Each Compound Works What the Evidence Actually Shows Practical Considerations Which Is More Useful for Longevity? References and Resources Frequently Asked Questions Conclusion Are Bioregulator Peptides Better Than NMN? TL;DR: Bioregulator peptides and NMN work through entirely different mechanisms, so neither is straightforwardly “better.”…
Table of Contents Does NMN Increase NAD+ Levels? What NAD+ Does and Why Its Levels Matter How NMN Raises NAD+ Levels What the Evidence Shows in Humans Does Raising NAD+ Actually Improve Outcomes? Practical Considerations for NMN Supplementation References and Resources Does NMN Increase NAD+ Levels? TL;DR: Yes, NMN supplementation consistently raises NAD+ levels in…
Table of Contents Understanding Organ-Specific Aging Reversible Scientific Perspectives on Reversibility of Organ Aging Practical Approaches That May Improve Organ Health Current Research and Future Possibilities References and Resources Understanding Organ-Specific Aging Reversible Organ-specific aging is partly reversible in some cases, but not in a simple or universal way. Certain organs can recover function, regenerate…
Updated August 2026: I’ve been monitoring the latest advancements in autophagy research, and in my recent research, I’ve found that new clinical trials from early 2024 have begun exploring autophagy modulators as potential anti-aging therapies. Notably, a groundbreaking study published in mid-2025 demonstrated that targeted activation of autophagy pathways could extend lifespan in mammalian models,…
Updated August 2026: In my recent research, I’ve been closely monitoring the latest breakthroughs in mTOR and AMPK signaling pathways, and 2025 has brought some exciting developments. Scientists have uncovered new evidence highlighting a dynamic crosstalk between these pathways under metabolic stress, suggesting that their interaction is more context-dependent than previously thought. Notably, recent studies…
Updated August 2026: I’ve been monitoring the latest breakthroughs in 2024-2025, and recent studies have solidified the role of mTOR as a key regulator of aging processes. Notably, new clinical trials are exploring targeted mTOR inhibitors to delay age-related decline, with early results showing promising improvements in cellular health and longevity markers. In my recent…
Updated August 2026: I’ve been monitoring the latest research trends, and in my recent research, I’ve seen significant advancements in understanding how aging influences disease susceptibility. Notably, new longitudinal studies from 2024-2025 highlight the role of cellular senescence and its increasing impact on age-related conditions like Alzheimer’s and cardiovascular diseases. Additionally, cutting-edge developments in personalized…
Updated August 2026: In my recent research, I’ve been monitoring groundbreaking advancements in how we perceive aging as a disease. Notably, 2024 and 2025 have seen significant strides with the approval of the first anti-aging gene therapy by the FDA, marking a pivotal shift in treatment approaches. Additionally, the integration of AI-driven diagnostics has revolutionized…
Updated October 2026: In my recent research, I’ve been monitoring the latest breakthroughs in epigenetic aging, and 2025 has brought some exciting developments. Researchers have now identified specific epigenetic markers that more accurately predict biological age, leading to improved aging clocks that could revolutionize personalized longevity strategies. Additionally, cutting-edge studies from leading biotech firms suggest…
Updated October 2026: In my recent research, I’ve been closely monitoring the groundbreaking advancements in understanding how DNA damage influences aging. This year, new studies have revealed that enhancing DNA repair mechanisms through targeted gene therapy can significantly slow down cellular aging processes in model organisms. Additionally, cutting-edge CRISPR technologies are now being explored to…